We reveal a trove of niche-ass protein snacks, including a Canadian sweet potato-based Orange Creamsicle bar, a beef tallow ...

The Phase 3 study is a global trial to evaluate improvements in both pain and function for up to 12 months following a MOTYS ...

Aroa Biosurgery Ltd ( ($AU:ARX) ) has provided an update. Aroa Biosurgery Ltd has released its Q2 quarterly cashflow report, emphasizing its ...

Uncontrolled bleeding during surgery remains one of the deadliest medical emergencies. Injuries to internal organs such as ...

Extracellular matrix Xceed TL features a natural scaffold rich in extracellular matrix (ECM), which supports native ...

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will report 2025 third ...

South Korea's Hyundai ADM Bio said its new cancer drug under development, Penetrium, may prove effective treating diseases ...

For a long time, we have known that loss of bone or permanent teeth cannot be reversed. If you experience a chipped tooth or ...

MICVO received Fast Track Designation from the U.S. Food and Drug Administration for the treatment of adult patients with R/M HNSCC whose disease has progressed following treatment with platinum-based ...

The field of dystroglycan (DG) research has garnered significant attention due to its critical role as a non-integrin adhesion complex that bridges the extracellular matrix and the cytoskeleton. DG's ...

Regenerative medicine is a fast-growing field harnessing the body’s natural healing ability and has become a focus for several ASX biotechs.